Advertisement
Strategies & Technologies Driving Drug Discovery to Market
Subscribe to Drug Discovery & Development All
View Sample

FREE Email Newsletter

DDD Update

Daily news and top headlines for drug research professionals

Human Clinical Trials Planned for New Anti-Cancer Compound

April 23, 2015 8:55 am | by University of Auckland | News | Comments

Researchers developed a new anti-cancer compound that will advance to human phase two clinical trials. Read more...

TOPICS:

Alcoholic Hepatitis Treatments Fail to Keep Patients Alive

April 23, 2015 8:51 am | by Imperial College London | News | Comments

The main drugs used to treat alcoholic hepatitis are not effective at increasing patients' survival. Read more...

TOPICS:

WHO: Global Vaccination Records 'Off-Track'

April 23, 2015 8:45 am | News | Comments

Progress towards global vaccination targets for 2015 is far off-track with 1 in 5 children still missing out on routine life-saving immunizations that could avert 1.5 million deaths each year from preventable diseases. Read more...

TOPICS:
Advertisement

Boosting the Malaria Battle-Line

April 23, 2015 8:39 am | by University of Melbourne | News | Comments

Researchers have discovered how the malaria parasite protects itself by building resistance against the last-line in antimalarial medications. Read more...

TOPICS:

Link Between Serotonin and Depression is a Myth, Says Psychiatrist

April 22, 2015 2:11 pm | by Stephanie Guzowski, Editor | News | Comments

The widely held belief that depression is caused by low levels of serotonin and that certain antidepressants raise the levels of this neurotransmitter, is a myth, according to a psychiatrist in an editorial article in The BMJ this week. Read more...

TOPICS:

Harnessing the Clinical Potential of Microvesicles Released from Cancer Cells

April 22, 2015 12:14 pm | by William G. Gilroy, University of Notre Dame | News | Comments

Over the past few years, extracellular vesicles, or membrane sacs secreted from cells, have emerged as important mediators by which cells communicate with their surroundings to regulate a diverse range of biological processes. Read more..

TOPICS:

New Candidate Drug 'Dials Down' Protein Synthesis

April 22, 2015 12:07 pm | by University at Buffalo | News | Comments

UB researcher contributes to study on new candidate drug that may help treat misfolded protein diseases like CMT, Alzheimer’s and Parkinson’s. Read more...

TOPICS:

Iluvien Now Widely Available To DME Patients Throughout U.S.

April 22, 2015 11:54 am | News | Comments

Alimera Sciences, Inc. (Alimera), a pharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals, announced today that many retina specialists throughout the U.S. are now using Iluvien. Read more..

Advertisement

With Bird Flu Spreading, USDA Starts on Potential Vaccine

April 22, 2015 11:47 am | by Steve Karnowski, Associated Press | News | Comments

The U.S. Department of Agriculture is working on a vaccine to counter a deadly strain of bird flu, as losses to poultry producers mount. Read more...p

TOPICS:

AACR 2015: Pembrolizumab Comes Out on Top for Melanoma, Lung Cancer

April 22, 2015 10:33 am | by Stephanie Guzowski, Editor | Articles | Comments

At the AACR Annual Meeting 2015, immunotherapies, called PD-1 inhibitors, were front and center stage, due to clinical trial results that led to U.S. Food and Drug Administration (FDA) approvals for treating melanoma and non-small cell lung cancer (NSCLC). Read more..

TOPICS:

Regulatory and Clinical Factors Limiting U.S. Non-Vascular Stent Market Growth

April 22, 2015 9:43 am | by Priya Radhakrishnan, Director of Medical Devices, GlobalData | News | Comments

The future growth of the non-vascular stent market by 2021 will be slower in the US than almost every other major market, due in part to an increasingly difficult regulatory process and the medical device excise tax, but primarily as a result of clinical factors and unmet needs still to be addressed, said research and consulting firm GlobalData. Read more...

TOPICS:

Takeda: Research Collaboration with Keio University School of Medicine, Niigata University

April 21, 2015 3:36 pm | News | Comments

This will focus on the search for and functional analysis of disease-related RNA-binding proteins. Read more...

TOPICS:

GW Pharmaceuticals Initiates Second Phase 3 Trial for Epidiolex

April 21, 2015 3:15 pm | News | Comments

This drug is intended for the treatment of Dravet syndrome. Read more...

TOPICS:

Lupin Launches Zaxine in Canada

April 21, 2015 3:08 pm | News | Comments

The agreement grants Lupin exclusive rights to promote, distribute and market Zaxine in Canada. Read more...

TOPICS:

Trial Shows Benefit of 'BRCA-targeting' Drug in Prostate Cancer

April 21, 2015 3:00 pm | by Institute of Cancer Research | News | Comments

Men with prostate cancer benefit from treatment with the pioneering drug olaparib. Read more...

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading